This section presents information about the death rate statistics
for the various types of Systemic disorders.
Disease | Death Rate Estimate | US deaths estimate | Statistic Used for Calculation |
| Mitochondrial disorders |
N/A |
N/A |
No information
|
| Metabolic disorders |
N/A |
N/A |
No information
|
| Aging |
N/A |
N/A |
No information
|
| Diabetes |
approx 1 in 17 or 5.88% or 16 million people in USA |
16 million Americans with 10.3 million diagnosed and 8.1 million women (NWHIC); 65 per 1000 - NHIS95; 8 million - perhaps 16 million if include not-yet-diagnosed. |
16 million Americans with 10.3 million diagnosed and 8.1 million women (NWHIC); 65 per 1000 - NHIS95; 8 million - perhaps 16 million if include not-yet-diagnosed.
|
| Insulin Resistance |
N/A |
N/A |
about 25% of the USA population have insulin resistance
|
| Metabolic Syndrome |
N/A |
N/A |
about 25% of the USA population have insulin resistance
|
| Systemic lupus erythematosus |
N/A |
N/A |
1.4 million people in the United States, 1 in 85 (NWHIC)
|
| Diabetes Insipidus |
N/A |
N/A |
No information
|
| Cushing's syndrome |
N/A |
N/A |
2-5 per million (NIDCD); 10 per million; 10-15 per million
|
| Hypertension |
approx 1 in 5 or 18.38% or 50 million people in USA |
50 million Americans (NHLBI); 217 per 1000 (NHIS95) |
50 million Americans (NHLBI); 217 per 1000 (NHIS95)
|
| Hypercholesterolemia |
N/A |
N/A |
estimated 101 million Americans have cholesterol >= 200 mg/dL (CDC)
|
| Hemochromatosis |
approx 1 in 272 or 0.37% or 1 million people in USA |
more than 1 million Americans (CDC); 5 per 1000 in Caucasians (NIDDK); 1-in-200 to 1-in-300 |
more than 1 million Americans (CDC); 5 per 1000 in Caucasians (NIDDK); 1-in-200 to 1-in-300
|
| Wilson's Disease |
N/A |
N/A |
approximately 1 per 30,000 people suffer from Wilson disease, Genetics Home Reference website
|
| Addisonian crisis |
N/A |
N/A |
No information
|
| Alkalosis |
N/A |
N/A |
No information
|
| Acidosis |
N/A |
N/A |
No information
|
| Anaphylaxis |
unavailable |
|
No information
|
| Hangover |
N/A |
N/A |
No information
|
| Pituitary conditions |
N/A |
N/A |
No information
|
| Atherosclerosis |
approx 1 in 58 or 1.70% or 4.6 million people in USA |
17 per 1000 - NHIS95 |
17 per 1000 - NHIS95
|
| Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 17 |
N/A |
N/A |
No information
|
| Physical conditions |
N/A |
N/A |
No information
|
| Chronic Illness |
approx 1 in 3 or 33.09% or 90 million people in USA |
90 million people in USA (CDC) |
90 million people in USA (CDC)
|
| Paralysis |
N/A |
N/A |
9 per 1000 - NHIS95 (paralysis of extremeties complete/partial)
|
| Multiple Sclerosis, Susceptibility To, 1 |
N/A |
N/A |
No information
|
| Multiple Sclerosis, Susceptibility To, 2 |
N/A |
N/A |
No information
|
| Multiple Sclerosis, Susceptibility To, 3 |
N/A |
N/A |
No information
|
| Multiple Sclerosis, Susceptibility To, 4 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 12 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 11 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 10 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 9 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 8 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 7 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 6 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 5 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 4 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 3 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 2 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 1 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus with Vitiligo, Susceptibility to, 1 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus with Hemolytic Anemia, Susceptibility to, 1 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus with Nephritis, Susceptibility to, 1 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 13 |
N/A |
N/A |
No information
|
| Metabolic syndrome (syndrome X) |
N/A |
N/A |
No information
|
| Cushing's syndrome-induced hypertension |
N/A |
N/A |
No information
|
| Systemic lupus erythematoses |
N/A |
N/A |
No information
|
| Bullous systemic lupus erythematosus |
N/A |
N/A |
No information
|
| Volume depletion |
N/A |
N/A |
No information
|
| Dehydration |
N/A |
N/A |
No information
|
| Relapsing/remitting multiple sclerosis |
N/A |
N/A |
No information
|
| Secondary chronic progressive multiple sclerosis |
N/A |
N/A |
No information
|
| Primary progressive multiple sclerosis |
N/A |
N/A |
No information
|
| Marburg multiple sclerosis |
N/A |
N/A |
No information
|
| Optic-spinal form of multiple sclerosis |
N/A |
N/A |
No information
|
| Accidental death |
unavailable |
|
No information
|
| Maternal death |
unavailable |
|
No information
|
| Systemic Juvenile Rheumatoid Arthritis |
N/A |
N/A |
No information
|
| Tuberous sclerosis |
N/A |
N/A |
less than 1 in 10,000
|
| Balo disease |
N/A |
N/A |
No information
|
| Autoimmune Vasculitis |
N/A |
N/A |
No information
|
| Autoimmune Atherosclerosis |
N/A |
N/A |
No information
|
| Metabolic Acidosis |
N/A |
N/A |
No information
|
| Multiple Sclerosis |
N/A |
N/A |
1-in-700 (NIAID)
|
| Systemic candidiasis |
N/A |
N/A |
No information
|
| Systemic mastocytosis |
N/A |
N/A |
No information
|
| Shock, Cardiogenic |
N/A |
N/A |
No information
|
| Shock, Hypovolaemic |
N/A |
N/A |
No information
|
| Shock, Neurogenic |
N/A |
N/A |
No information
|
| Shock, Septic |
N/A |
N/A |
No information
|
| Shock, Traumatic |
N/A |
N/A |
No information
|
| Shock, Obstructive |
N/A |
N/A |
No information
|
| Shock, anaphylactic |
N/A |
N/A |
No information
|
| Shock, Endocrine |
N/A |
N/A |
No information
|
| Shock, Distributive |
N/A |
N/A |
No information
|
| Wasting Syndrome |
N/A |
N/A |
No information
|
| Water Intoxication |
N/A |
N/A |
No information
|
| Systemic monochloroacetate poisoning |
N/A |
N/A |
No information
|
| Glaucoma associated with systemic abnormalities |
N/A |
N/A |
No information
|
| Renal failure-like electrolyte imbalances |
N/A |
N/A |
No information
|
| Excessive diaphoresis |
N/A |
N/A |
No information
|
| AIDS wasting syndrome |
N/A |
N/A |
No information
|
| Acute rheumatic fever |
unavailable |
|
No information
|
| Anoxemia |
N/A |
N/A |
No information
|
| Anoxia |
N/A |
N/A |
No information
|
| Polyarthritis, systemic |
N/A |
N/A |
No information
|
| Portuguese type amyloidosis |
N/A |
N/A |
No information
|
| Hereditary amyloidosis |
N/A |
N/A |
No information
|
| Primary amyloidosis |
N/A |
N/A |
No information
|
| Dialysis-related amyloidosis |
N/A |
N/A |
No information
|
| Amyloidosis |
N/A |
N/A |
less than 3,000 people in the US (Mayo Clinic)
|
| A ?-protein amyloidosis |
N/A |
N/A |
No information
|
| Amyloidosis AL |
N/A |
N/A |
No information
|
| Amyloidosis beta2-microglobulinic |
N/A |
N/A |
No information
|
| Amyloidosis, inflammatory |
N/A |
N/A |
No information
|
| Immunoglobulinic amyloidosis |
N/A |
N/A |
No information
|
| Rheumatic fever |
unavailable |
|
No information
|
| Hereditary carnitine deficiency syndrome, systemic |
N/A |
N/A |
No information
|
| Leukocytoclastic angiitis -- systemic |
N/A |
N/A |
No information
|
| Familial Granulomatosis, Blau type |
N/A |
N/A |
No information
|
| Familial, Systemic, Juvenile Granulomatosis |
N/A |
N/A |
No information
|
| Systemic Capillary Leak Syndrome |
N/A |
N/A |
No information
|
| Scleroderma, systemic |
N/A |
N/A |
No information
|
| Spontaneous periodic hypothermia |
N/A |
N/A |
No information
|
| Hyalinosis, infantile systemic |
N/A |
N/A |
No information
|
| Aggressive systemic mastocytosis |
N/A |
N/A |
No information
|
| Cushing syndrome, familial |
N/A |
N/A |
No information
|
| Diffuse systemic sclerosi |
N/A |
N/A |
No information
|